lexiara

(c)

CRR3

the treatment does not significantly reduce the total own funds requirements for market risk of the institutions applying it;

· All articles ·

Source: EUR-Lex CELLAR · retrieved 2026-09-04 · Text as adopted (Official Journal); later amendments are not incorporated in this text.